April 23, 2020 / 9:39 PM / a month ago

BRIEF-Moleculin Biotech Received Letter From Nasdaq Notifying Company That It Had Regained Compliance With Nasdaq Listing Rule

April 23 (Reuters) - Moleculin Biotech Inc:

* MOLECULIN BIOTECH INC - ON APRIL 23, CO RECEIVED LETTER FROM NASDAQ NOTIFYING COMPANY THAT IT HAD REGAINED COMPLIANCE WITH NASDAQ LISTING RULE

* MOLECULIN BIOTECH INC - COMPANY IS IN COMPLIANCE WITH BID PRICE RULE AND NASDAQ CONSIDERS MATTER CLOSED Source text: [bit.ly/3eNqtMY] Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below